Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
Background/Aims. Pancreatic ductal adenocarcinoma (PDA) has etiological association with chronic inflammation. Elevated circulating levels of inflammatory mediators, such as monocyte chemoattractant protein-1 (MCP-1), are found in obese individuals. We hypothesized that serum MCP-1 levels are eleva...
Main Authors: | Sullivan, Jennifer, Gong, Qiaoke, Hyslop, Terry, Lavu, Harish, Chipitsyna, Galina, Yeo, Charles J., Arafat, Hwyda A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184439/ |
Similar Items
-
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion—Preliminary Observations
by: Sarosiek, Konrad, et al.
Published: (2016) -
Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
by: Radhakrishnan, Preethi, et al.
Published: (2014) -
Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
by: Morimoto, Hajime, et al.
Published: (2007) -
Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
by: Lim, Jun Pei, et al.
Published: (2015) -
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
by: Petrkova, Jana, et al.
Published: (2004)